![](http://media.springernature.com/relative-r300-703_m1050/springer-static/image/art%3A10.1038%2Fnrd1511/MediaObjects/41573_2004_Article_BFnrd1511_Illa1_HTML.jpg)
●Strategies for disease modification in Alzheimer's disease. Citron, M. Nature Reviews Neuroscience September (2004)
●Special focus: antimicrobial strategies.Nature Reviews Microbiology September (2004) Articles include:
●Seeing is believing: the impact of structural genomics on antimicrobial discovery. Schmid, M. B.
●Passive antibody therapy for infectious diseases. Casadevall, A. Dadachova, E. & Pirofski, L. -A.
●Antivirals and antiviral strategies. De Clercq, E.
●Antiprion immunotherapy: to suppress or to stimulate? Aguzzi, A. & Sigurdson, C. J. Nature Reviews Immunology September (2004)
●RNAi quashes polyQ Caplen, N. J. Nature Biotechnology August (2004) A News and Views piece on a paper showing that RNA interference as therapy for neurodegenerative disease leads to improvements in cellular and behavioural abnormalities in a mouse model of spinocerebellar ataxia.
●Zooming in and out with quantum dots Jain, R. K. & Stroh, M. Nature Biotechnology August (2004) Multifunctional nanoparticle probes based on semiconductor quantum dots show promise for in vivo cancer targeting and imaging.
●Breast cancer progression with a Twist Thiery, J. P. & Morgan, M. Nature Medicine August (2004)
●Treating cancer's kinase 'addiction' Baselga, J. & Arribas, J. Nature Medicine August (2004)
●Redesigner drugs Dove, A. Nature Biotechnology August (2004)
●The articles listed below were published in Nature Reviews Genetics (September 2004) to form a joint Focus on Pharmacogenetics that includes articles in this issue of Nature Reviews Drug Discovery
●Pharmacogenetics and drug development: prospective pipeline strategies for safer and more effective drugs. Roses, A.
●Genetically modified mouse models for pharmacogenomics research. Liggett, S. B.
●Integrating pharmacogenetics into society: in search of a model. Webster, A., Martin, P., Lewis, G. & Smart, A.
●Pharmacogenetics — five decades of therapeutic lessons from genetic diversity. Meyer, U. A.
●Pharmacogenetics: ethical problems and solutions. Breckenridge, A., Lindpaintner, K., Lipton, P., McLeod, H., Rothstein, M. & Wallace, H.
Rights and permissions
About this article
Cite this article
Reviews and comment from the nature publishing group. Nat Rev Drug Discov 3, 1 (2004). https://doi.org/10.1038/nrd1511
Issue Date:
DOI: https://doi.org/10.1038/nrd1511